Lisa Butterfield on the Nurse's Role in Immunotherapy Treatment

December 9, 2016

Video

Lisa Butterfield discusses what nurses should know when treating patients receiving immunotherapies.

Lisa Butterfield, PhD, University of Pittsburgh and president of the Society of Immunotherapy for Cancer (SITC), describes what nurses should know when dealing with immunotherapy treatments.

During the Nurse track at the most recent SITC Annual Meeting, Butterfield hopes that nurses would come away with a knowledge of the options available, how the different drugs work, and how that affects the patient experience. This information should also help nurses in talking to patients and empower them when treating patients receiving immunotherapies.

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!

Related Content

Photo of a woman with brown hair and bangs, surrounded by a blue border

AE Education Aids Breast Cancer Decisions, Says Survivorship Expert

Michelle Kirschner, RN, MSN, ACNP, APRN-BC

June 30th 2025

Article

Planning for adverse effects early on helps patients prepare for what lies ahead, says Michelle Kirschner, MSN, RN, ACNP, APRN-BC.

Ask The Right Questions: Clinical Pearls of AE Management

Lindsay Fischer

February 15th 2022

Podcast

In this episode of “The Vitals,” Mark Honor, PA-C, discusses adverse event management in patients receiving different therapeutic options.

conceptual image of head and neck against yellow background

Stopping ICIs at 1 or 2 Years May Not Compromise Survival in HNSCC

Spencer Feldman

September 11th 2024

Article

This retrospective, population-based study shows strong efficacy across multiple patient subgroups and different lines of therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma.